Fingerprint
Dive into the research topics of 'Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months
Melissa P. Wasserstein, George A. Diaz, Robin H. Lachmann, Marie Hélène Jouvin, Indrani Nandy, Allena J. Ji, Ana Cristina Puga
Research output: Contribution to journal › Article › peer-review
79
Scopus
citations